Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

vitalis de panamÁ s.a. - n-butilbromuro de hioscina - n-butilbromuro de hioscina....20,00 mg / dipirona sodica monohidratada....2,50 g

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

vitalis s.a.c.i. - bromuro de vecuronio - bromuro de vecuronio....10.00 mg

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

certis belchim nv - metobromuron - unknown - metobromuron active 0.0 - active constituent

United States - English - NLM (National Library of Medicine)

alk-abello, inc. - bromus inermis pollen (unii: 766qt72bk6) (bromus inermis pollen - unii:766qt72bk6) - bromus inermis pollen 10000 [pnu] in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants, in situations where the offending allergen cannot be avoided. prior to the initiation of therapy, clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can be easily avoided. a patient should not be immunized against a substance which the patient has not demonstrated symptoms and/or tissue-fixed ige antibodies as demonstrated by skin testing. immunotherapy should not be attempted in patients with active asthma, severe respiratory obstruction, or cardiovascular disease. there is some evidence, although inconclusive, that routine immunizations may exacerbate autoimmune diseases. hyposensitization should be given cautiously to patients with this predisposition. the physician must w

United States - English - NLM (National Library of Medicine)

jubilant hollisterstier llc - bromus inermis pollen (unii: 766qt72bk6) (bromus inermis pollen - unii:766qt72bk6) - bromus inermis pollen 0.05 g in 1 ml - certain diagnostics carry labeling which states allergenic extract for diagnostic use only . data to support the therapeutic use of products labeled with this statement have not been established. 14 in addition to a carefully taken history, the use of glycerin-containing extracts in scratch, prick or puncture testing is an accepted method in the diagnosis of allergic conditions. 1, 2, 3 extracts of all allergens do not produce equivalent results in scratch, prick or puncture tests. the intensity of the skin reactions produced will be determined by two factors: the degree of sensitivity of the patient, and the nature of the allergenic extract applied. scratch, prick or puncture tests are not as sensitive as the intradermal test, but are safer and cause less discomfort. they may, therefore, be the method of choice when a large number of tests are needed, or when testing the pediatric patient. in some cases, where the relatively insensitive scratch, prick or puncture tests are negative or do not confirm the

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

pharmayect s.a. - rocuronio bromuro - rocuronio bromuro....50mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

fresenius kabi austria gmbh - rocuronio bromuro - rocuronio bromuro....10 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

as kalceks - rocuronio bromuro - rocuronio bromuro....10.0 mg.

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

beximco pharmaceuticals ltd - hioscina butilbromuro - hioscina butilbromuro....10mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

vitalis de panamÁ s.a. - rocuronio bromuro - rocuronio bromuro....50.00 mg.